The fact
It targets adults and adolescents over 15, with a simplified dosage.
This approval reignites the debate on access to psychiatric care in Europe.
2 sources — click a link to read an article on the topic:
It targets adults and adolescents over 15, with a simplified dosage.
This approval reignites the debate on access to psychiatric care in Europe.